R5	Appositive Attribute:T25 Head:T8
R6	PredicateNominative Attribute:T24 Head:T13
R7	PredicateNominative Attribute:T26 Head:T8
R8	Anaphora Anaphor:T47 Antecedent:T1
T1	Drug_Class 1838 1866	nitric oxide donor compounds
T2	Drug 1878 1898	sodium nitroprusside
T3	Drug 1903 1916	nitroglycerin
T5	Drug 1951 1957	INOmax
T6	Drug 2026 2036	prilocaine
T10	Drug 1710 1720	dobutamine
T11	Drug 1700 1708	dopamine
T12	Drug 0 6	INOMAX
T13	Drug 28 34	INOmax
T14	Drug 130 136	INOmax
T15	Drug 188 194	INOmax
T16	Drug 369 375	INOmax
T17	Drug 745 751	INOmax
T18	Drug 815 821	INOmax
T19	Drug 1654 1660	INOmax
T20	Drug_Class 1722 1730	steroids
T21	Drug_Class 1541 1552	medications
T8	Drug 92 104	Nitric oxide
T24	IndefiniteNP 57 63	a drug
T25	DefiniteNP 106 126	the active substance
T26	IndefiniteNP 141 164	a pulmonary vasodilator
T27	DefiniteNP 217 230	the treatment
T28	DefiniteNP 509 517	the dose
T29	ZeroArticleNP 745 759	INOmax therapy
T30	DefiniteNP 924 948	the methemoglobin levels
T31	IndefiniteNP 975 983	a period
T32	DefiniteNP 1136 1154	the first 48 hours
T33	DefiniteNP 1156 1172	The 80 ppm group
T34	IndefiniteNP 1177 1198	a mean peak NO2 level
T35	ZeroArticleNP 1412 1418	7 DRUG
T36	DefiniteNP 1561 1574	the treatment
T37	DefiniteNP 1634 1652	the available data
T38	IndefiniteNP 1493 1529	a clinically significant interaction
T39	IndefiniteNP 1535 1552	other medications
T40	DefiniteNP 1821 1836	the possibility
T41	DefiniteNP 1961 1969	the risk
T42	IndefiniteNP 1927 1945	an additive effect
T43	ZeroArticleNP 1838 1866	nitric oxide donor compounds
T44	IndefiniteNP 2003 2017	An association
T45	IndefiniteNP 2041 2058	an increased risk
T46	IndefiniteNP 2141 2165	a literature case report
T47	DefiniteNP 2196 2205	the drugs
T48	DemonstrativeNP 2167 2176	This risk
T49	ZeroArticleNP 2247 2267	topical formulations
